We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$20.3B
AUM Growth
+$1.22B
(+6.4%)
Cap. Flow
-$160M
Cap. Flow
% of AUM
-0.79%
Top 10 Holdings %
Top 10 Hldgs %
22.03%
Holding
1,796
New
121
Increased
266
Reduced
599
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE
T1 Energy
TE
|
+$60.5M |
| 2 |
Pfizer
PFE
|
+$44M |
| 3 |
GXO Logistics
GXO
|
+$37.3M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$31.2M |
| 5 |
JD.com
JD
|
+$29.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$57.2M |
| 2 |
Alibaba
BABA
|
+$57.2M |
| 3 |
Ameresco
AMRC
|
+$55.4M |
| 4 |
SIVB
SVB Financial Group
SIVB
|
+$43.1M |
| 5 |
Wolfspeed
WOLF
|
+$41.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.22% |
| 2 | Healthcare | 17.92% |
| 3 | Consumer Discretionary | 13.84% |
| 4 | Financials | 12.09% |
| 5 | Industrials | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Andersons Inc
ANDE
$2.22B
| $334K | ﹤0.01% |
8,623
-300
| -3% | -$10.5K |
|
|
CERE
1577
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $334K | ﹤0.01% |
+10,300
| New | +$363K |
|
1578
BridgeBio Pharma
BBIO
$16B
| $333K | ﹤0.01% |
19,950
-4,800
| -19% | -$203K |
|
|
SCS
1579
DELISTED
Steelcase
SCS
| $333K | ﹤0.01% |
28,418
| – | – |
|
1580
8x8 Inc
EGHT
$289M
| $331K | ﹤0.01% |
19,725
-325,000
| -94% | -$6.81M |
|
|
UHT
1581
Universal Health Realty Income Trust
UHT
$575M
| $331K | ﹤0.01% |
5,565
| – | – |
|
1582
Palomar
PLMR
$3.36B
| $330K | ﹤0.01% |
5,100
| – | – |
|
1583
LendingTree
TREE
$446M
| $329K | ﹤0.01% |
2,686
| – | – |
|
1584
IMAX
IMAX
$2.89B
| $328K | ﹤0.01% |
18,395
| – | – |
|
|
TBI
1585
Trueblue
TBI
$303M
| $327K | ﹤0.01% |
11,816
| – | – |
|
1586
Atlanta Braves Holdings Series B
BATRK
$3.42B
| $325K | ﹤0.01% |
11,560
| – | – |
|
1587
Sonos
SONO
$1.87B
| $325K | ﹤0.01% |
10,900
-19,700
| -64% | -$627K |
|
1588
ACM Research
ACMR
$5.79B
| $324K | ﹤0.01% |
11,400
-5,100
| -31% | -$161K |
|
1589
Alector
ALEC
$232M
| $324K | ﹤0.01% |
15,700
-1,100
| -7% | -$24.8K |
|
|
ACCD
1590
DELISTED
Accolade Inc
ACCD
| $324K | ﹤0.01% |
12,300
| – | – |
|
1591
Repay Holdings
RPAY
$308M
| $323K | ﹤0.01% |
17,700
| – | – |
|
1592
Worthington Enterprises
WOR
$2.82B
| $323K | ﹤0.01% |
9,596
-5,352
| -36% | -$176K |
|
1593
Madrigal Pharmaceuticals
MDGL
$11.9B
| $322K | ﹤0.01% |
3,800
+1,100
| +41% | +$90.4K |
|
|
KYNB
1594
Kyntra Bio
KYNB
$28.7M
| $321K | ﹤0.01% |
912
+144
| +19% | +$44.8K |
|
|
PRO
1595
DELISTED
PROS Holdings
PRO
| $321K | ﹤0.01% |
9,300
| – | – |
|
|
IMGN
1596
DELISTED
Immunogen Inc
IMGN
| $321K | ﹤0.01% |
43,300
| – | – |
|
|
SRNE
1597
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $321K | ﹤0.01% |
69,100
+7,800
| +13% | +$48.4K |
|
1598
Westamerica Bancorp
WABC
$1.38B
| $319K | ﹤0.01% |
5,530
| – | – |
|
1599
The GEO Group
GEO
$4.05B
| $317K | ﹤0.01% |
40,900
| – | – |
|
1600
Globalstar
GSAT
$10.7B
| $316K | ﹤0.01% |
18,160
-17,320
| -49% | -$380K |
|
Similar funds
VIA
GAM
Handelsbanken Fonder's Q4 2021 Portfolio in Review
As of Q4 2021, Handelsbanken Fonder held 1,796 positions worth $20.3B, up 6.4% from $19.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Handelsbanken Fonder's Q4 2021 filing shows 121 new, 266 increased, 599 reduced and 60 closed positions. Its largest new stake was T1 Energy: 5,589,851 shares worth $62.5M. The largest sale was NVIDIA, an estimated $57.2M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Handelsbanken Fonder's largest Q4 2021 buy was T1 Energy: 5,589,851 shares worth $62.5M.
- Handelsbanken Fonder added most to Pfizer in Q4 2021, an estimated $44M increase.
- Handelsbanken Fonder's biggest Q4 2021 reduction was NVIDIA, cutting an estimated $57.2M.
- Handelsbanken Fonder fully exited Acceleron Pharma in Q4 2021, selling an estimated $27.5M.
- Handelsbanken Fonder's ten largest holdings make up 22% of its $20.3B portfolio in Q4 2021.
- Handelsbanken Fonder opened 121 new positions and closed 60 in Q4 2021.
- Handelsbanken Fonder's portfolio value rose 6.4% quarter-over-quarter to $20.3B.
Based on Handelsbanken Fonder's 13F filing for Q4 2021, filed 8 Feb 2022.